Antibiotic resistance is found everywhere. Drug-resistant bacteria infected persons are at high risk which can make clinical outcomes worse sometimes even death, It also consumes more health-care resources more than non-resistant strains infected patients of the constant bacteria.
Common intestinal bacteria(K. pneumonia) have the capability of causing life-threatening infections – to the last resort treatment have been spread to all over the world. Major hospital-acquired infections such as pneumonia, infections in the bloodstream, and new-borns infections and intensive-care unit patients are caused by K. pneumonia. Because of resistance, carbapenem antibiotics do not work in more than half of people treated for K. pneumonia infections in some countries.
- coil resistance is the most widely used medicines to treat urinary tract infections. But in some countries, this treatment is not effective to some patients. Guidelines for gonorrhea to address emerging resistance treatment is recently updated by World Health Organisation.
Quinolones for the treatment of gonorrhea due to widespread high levels of resistance is not recommended in the new WHO guidelines. Guidelines for the treatment of chlamydial infections and syphilis was updated. People with MRSA (methicillin-resistant Staphylococcus aureus) are observed to be 64% chance of more likely to die than people with infection in non-resistant forms.
To Know about the recent updates, Join us at the “7th European Clinical Microbiology Congress” at London, the UK on Nov 01-03, 2018.